Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Mar 2011

Mantengoli Elisabetta, Luzzaro Francesco, Pecile Patrizia, Cecconi Daniela, Cavallo Annalisa, Attala Letizia, Bartoloni Alessandro, Rossolini Gian Maria

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Bacterial Typing Techniques
Share to beta-Lactamases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple, Bacterial

Share to Escherichia coli

Share to Escherichia coli Infections

Share to Microbial Sensitivity Tests

Share to Molecular Typing

Source

Identifiers

PMID: 21220769
DOI: 10.1093/cid/ciq194

Genes

VIM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.PMID 21220769Read ↗

Carbapenemase-Producing Gram-Negative Bacteria: Current Epidemics, Antimicrobial Susceptibility and Treatment OptionsSemantic proximity Read ↗

Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detectionSemantic proximity Read ↗

Imipenem Resistance: A Clarion Call to Antibiotic StewardshipSemantic proximity Read ↗

Clinical Management of Infections Caused by Enterobacteriaceae that Express Extended-Spectrum β-Lactamase and AmpC EnzymesSemantic proximity Read ↗

A Review on Bacterial Resistance to Carbapenems: epidemiology, Detection and Treatment OptionsSemantic proximity Read ↗

CTX-M-type β-lactamases: a successful story of antibiotic resistance.Semantic proximity Read ↗

The Growing Genetic and Functional Diversity of Extended Spectrum Beta-LactamasesSemantic proximity Read ↗

Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical LaboratorySemantic proximity Read ↗

β-Lactam Antibiotics and β-Lactamase Enzymes Inhibitors, Part 2: Our Limited ResourcesSemantic proximity Read ↗

Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.Semantic proximity Read ↗

Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternativesSemantic proximity Read ↗

Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.